In contrast, the EZB-MYC+ subtype, which is associated with concurrent MYC and BCL2 rearrangements (so-called “double-hit” lymphomas [DHL]), exhibited a relatively lower GC TFH signature. Here, BCL2 is linked to lymphoma.